The Importance of Psychological Treatment and Behavioral Support

Similar documents
2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders

The role of behavioral interventions in buprenorphine treatment of opioid use disorders

Opioid Use Disorder Treatment Initiation in Diverse Settings

Advances in Clinical Research for Prescription Opioid Dependence

Psychosocial Treatments for Opioid Use Disorder Overview

Evidence-Based Practice: Psychosocial Interventions

National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says

Improving Outcomes in Methadone Treatment

7/7/2016 Journal of the American Medical Association,

Opioids Research to Practice

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Addiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

V. EVIDENCE-BASED APPROACHES TO TREATING ADOLESCENT SUBSTANCE USE DISORDERS

Opioids Research to Practice

Substance Abuse Suboxone Treatment

Medication Assisted Treatment of Substance Use Disorders

The Opioid Crisis: What Can Physicians Do About It?

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

THE STATE OF MEDICINE IN ADDICTION RECOVERY

Models of good practice in drug treatment in Europe. Project group

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

Opioid Treatment in North Carolina SEPTEMBER 13, 2016

Treatment Approaches for Drug Addiction

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach. Van L. King, MD

Restoration of Parenting Ability Through Treatment for Substance Use Disorders

Opioids Research to Practice

ROSC & MAT II: Opioid Treatment Services

Latest Research on Addiction and Treatment

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Noel Schenk MD. Davis Behavioral Health

Health Systems and Addiction: Provider Issues

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

HARM REDUCTION & TREATMENT. Devin Reaves MSW

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Building capacity for a CHC response to Ontario's Opioid Crisis

Methadone Maintenance 101

What Predicts the Successful Completion of Addiction Treatment?

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Substance Abuse Level of Care Criteria

Overview of Medication Assisted Treatment Methadone, Buprenorphine and Naltrexone

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

National Conference of State Legislators

In the Doctor s Office

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

Buprenorphine as a Treatment Option for Opioid Use Disorder

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

The science of the mind: investigating mental health Treating addiction

IntNSA Webinar Series

Management of Opioid Use Disorder in Primary Care

Technology-Based Models for Substance Abuse Treatment Delivery: Lessons Learned

MARRCH Minnesota Society of Addiction Medicine Presents. Addiction as a Brain Disease

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Treatment Can Work. SELECT A TOPIC...

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Addiction as a Neuropsychiatric Medical Condition

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

MAT in the Corrections Setting

Drug Addiction Is a Disease So What Do We Do about It?

Appendix F Federation of State Medical Boards

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Addicted, Alone, Forgotten, and Ashamed

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Opioids Research to Practice

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

STARTING SUBOXONE IN PRIMARY CARE

Medication Assisted Treatment. Nicole Gastala, MD

Serious Mental Illness and Opioid Use Disorder

Mark Edlund, MD, PhD RTI International. Photo courtesy of The Herb Museum, Vancouver, BC

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Arwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry

DOWNLOAD OR READ : TREATING ADDICTIVE BEHAVIORS PDF EBOOK EPUB MOBI

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Addictions 101: Understanding, Recognizing, and Treating the Disease State!

Quality assurance in pharmacotherapy with methadone

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Addressing Alaska s Opioid Epidemic From Understanding to Action

Opiate Use Disorder and Opiate Overdose

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

Medication-Assisted Treatment (MAT) Overview

What is harm reduction?

3/21/2015. Leonardo Andrade, Ph.D. Westfield State University

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Addressing Opiate Abuse

ORGANIZATION OF AMERICAN STATES

Vivitrol/Suboxone. Comparison Study Summary

Transcription:

The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University

Conflicts and Acknowledgements No industry funding NIMH and NIDA funding, Royalties from books on CBT Acknowledgements Some slides from Lisa Onken, PhD, NIDA Some slides from R. Katherine McHugh, PhD, McLean

Effectiveness of Treatment Goal of treatment is to return to productive functioning Treatment reduced drug use by 40-60% Treatment reduces crime by 40-60% Treatment increases employment prospects by 40% Drug treatment is as successful as treatment of diabetes, asthma, and hypertension www.drugabuse.gov

HIV/AIDS, Hepatitis and Other Infectious Diseases Drug treatment is disease prevention Drug treatment reduces likelihood of HIV infection by 6 fold in injecting drug users Drug treatment presents opportunities for screening, counseling, and referral www.drugabuse.gov

Cost-Effectiveness of Drug Treatment Treatment is less expensive than not treating or incarceration (1 yr methadone maintenance = $4,700 vs. $18,400 for imprisonment) Every $1 invested in treatment yields up to $7 in reduced crime-related costs Savings can exceed costs by 12:1 when health care costs are included Reduced interpersonal conflicts Improved workplace productivity Fewer drug-related accidents www.drugabuse.gov

Let s start with the good news about psychosocial interventions Meta-Analyses offer the big picture, with a view of the efficacy when all studies are considered together

Psychosocial Treatment for Substance Dependence Meta-Analysis (39 comparisons) 0.8 0.7 0.6 0.5 0.4 0.3 Poly Cocaine Opiates Cannabis 0.2 0.1 0 Drugs of Use Dutra et al.,2008, Am J Psychiatry.

And we specifically assessed a question from a reviewer: Does the presence of agonist therapy change the efficacy of CBT? Need it to make CBT work Or don t need CBT when agonist therapy is on board Our meta-analysis said no, CBT works regardless of the backdrop of medication management

Psychosocial Treatment for Substance Dependence Meta-Analysis (39 comparisons) 1.2 1 0.8 0.6 0.4 General CBT Relapse Prevention Contingency Mgt BT + CM 0.2 0 Treatments Dutra et al.,2008, Am J Psychiatry

And we see translation of findings like these to clinical guidelines American Society on Addiction Medicine (2015) Recommendation that medication-assisted treatment include a psychosocial intervention

And to define my terms: CBT for OUD Modalities Individual and group drug counseling Cognitive behavioral therapy Contingency management/motivational incentives Majority of studies have been conducted with heroin users

Cognitive-Behavior Therapy Functional analysis of cues for use and consequences of use Review or Rehearsal to be ready for cues for use Development of alternatives and skills Cognitive coping skills Problem solving skills Assertiveness skills Activity assignments Non-drug environments/social contacts

Cognitive Restructuring I am an addict and I will always be an addict. I can t stand the way I feel (mood states or symptoms of withdrawal or craving are intolerable). Everything is horrible, I deserve to use. I deserve to feel good, therefore I am going to use.

Contingency Management (CM) Based on principles of operant conditioning Offer incentives or rewards to encourage specific behavioral goals In drug abuse treatment, rewards are typically contingent on negative toxicology screens Rewards have included prize vouchers, money, pleasant marital interactions Fishbowl techniques allow prize $ to go further

And now for some bad news about the efficacy of counseling for opioid dependence Amato et al., 2011. Psychosocial + agonist maintenance vs. agonist maintenance alone Meta Analysis of 35 studies 13 different psychosocial interventions Conclusion: adding psychosocial treatment did not add benefits for retention or drug use outcomes. However. 1. methodology of studies tested always included some psychosocial support in medication group 2. substantial heterogeneity of studies

What happened? Is it the changing type of opioid use? Is it due to use of general counseling instead of CBT? Is it due to stage of treatment? Is it due to the use of inadequate doses (which may include the failure to engage)? Do we need to use new strategies that better target habit over intention?

A Changing Population Opioid Admissions, Age 12-17 years 3500 Number of Admissions 3000 2500 2000 1500 1000 500 Heroin Rx opioids 0 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 03 04 05 06 7 8 9 10 11 12 Substance Abuse and Mental Health Services Administration, 2014

Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence SMM vs. SMM+ODC (Weiss et al., 2011, Arch Gen Psychiatry) SMM with recommendation to self help 4.5 visits Phase 1(12 wk) 14 visit Phase 2 (24 wk) ODC uses manualized treatment 6.6 visits Phase 1 11.6 visits Phase 2 No difference based on counseling sessions

Yet

Methadone Treatment with limited, standard, or enhanced counseling (Schwartz, 2012, Addiction) Limited counseling crossed over to standard after 4 months No differences in groups in 12 month drug use outcomes The authors point out: Emergency counseling was used Differences were found by McLellan et al., (1993, JAMA) with a veteran population. newly-admitted heroin users may not be ready to benefit from counseling or that methadone itself has such a powerful impact on the use of illicit heroin, that additional improvements with low levels of counseling could not be shown. CBT may have had a different effect

Is CBT needed?

Primary Care Buprenorphine +/- CBT (Fiellin et al., 2013, Am J Med) 141 Opioid dependent outpatients 12 Week CBT No alcohol, cocaine, or BZ dependence CBT: Functional analysis of behavior, promoting behavioral activation, identifying and coping with drug cravings, enhancing drug refusal skills, enhancing decision making around high risk situations, improving problem solving skills

Continued: Fiellin et al., 2013, Am J Med Control Treatment: review of drug use, provide advice on how to achieve or maintain abstinence, assess social, work, and legal functioning, review attendance at self-help groups. Nurses see patients 3 X week during initial 2 wk phase Attendance was approximately 6 of 8 sessions for physician visits Attendance was approximately 7 of 12 CBT visits

CBT-IC for Treatment Refractory Substance Dependence Patients in methadone maintenance and counseling were referred for treatment after chronically failing to control illicit drug use despite the above We randomized 78 individuals to 15 sessions CBT-IC or ODC (the active treatment by Weiss et al.) Otto et al., 2014, J Psychoactive Drugs

CBT: IC An exposure-based focus on distress tolerance rather than distress amelioration Core of Treatment: 5-step drug use protocol identification of external and internal cues for use discussion of alternatives to drug use in response to these cues; in session induction of the relevant (primarily emotional) cue for use practice of emotional labeling and acceptance of emotional states, and rehearsal of one or more non-drug response to the cues home practice of exposure and alternative responses And we found modest gains for both groups, with no between-treatment group differences

Stage of Treatment, Enough Treatment?? Note the consistency of low rates of delivery of psychosocial treatment (despite effort)

Does CBT earn its weight in $ Suggestion of yes, even with limited efficacy UK CBT vs. MM alone project Smaller Study CBT advantages were non-significant, but reflected a small to medium effect size (d=.28) CBT utilization was limited (mean 4.2 sessions) Costs were justified by resource savings Drummond et al., 2005

Other treatment targets 2016 Meta-Analysis Dugosh et al. Psychosocial treatment helps for something but not necessarily opioid use

New Strategies Recent evidence of insensitivity to outcomes Inability to learn contingency in fear conditioning paradigm (Basden et al., 2016) Failure to adapt to changing outcomes (Ersche et al., 2016, Science) Is there need for more habit based rehearsal interventions?

Summary Psychosocial treatments for substance abuse have a long history of success Recent challenges have been faced in opioid treatment. Psychosocial elements are always on board, but there is evidence that independent psychosocial treatment offers less than previous findings At this point, an explanation for this is not clear Low dose of psychosocial treatment is a characteristic across studies Phase of treatment issues may also be important